The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa)

Expert Opinion on Drug Safety

Volumn 3, Issue 6, 2004, Pages 615-623

  Huntley, Alyson ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Adverse events (AEs); Black cohosh; Herb drug interaction; Herbal medicine; Oestrogenic effects

Indexed keywords

CAFFEIC ACID; CIMICIFUGA RACEMOSA EXTRACT; DOPAMINE 2 RECEPTOR; ESSENTIAL OIL; ESTROGEN RECEPTOR; LUTEINIZING HORMONE; PHENOL DERIVATIVE; TAMOXIFEN; TANNIN DERIVATIVE; TRITERPENE;

ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; BILIARY TRACT DISEASE; BLOOD CLOTTING DISORDER; BODY WEIGHT DISORDER; BREAST CANCER; BREAST DISEASE; CANCER RECURRENCE; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONSTIPATION; DRUG CONTRAINDICATION; DRUG ERUPTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ENDOCRINE DISEASE; ENDOMETRIAL DISEASE; ENDOMETRIUM HYPERPLASIA; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HEPATITIS; HERBAL MEDICINE; HOT FLUSH; HUMAN; IN VITRO STUDY; INDIAN; INDIGESTION; LIBIDO DISORDER; LIVER DISEASE; LONG TERM CARE; MASTALGIA; MENOPAUSAL SYNDROME; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NONHUMAN; REVIEW; SKIN APPENDAGE DISEASE; SKIN DISEASE; THORAX PAIN; TRADITIONAL MEDICINE; UNPLEASANT SENSATION; URINARY TRACT DISEASE; VAGINA BLEEDING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CIMICIFUGA; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; DRUG SYNERGISM; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; HEPATITIS, AUTOIMMUNE; HOT FLASHES; HUMANS; MENOPAUSE; MICE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS; RATS; RECEPTORS, NEUROTRANSMITTER; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 8844283346     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.6.615     Document Type: Review

References (60)

1. MCKENNA DJ, JONES K, HUMPHREY S, HUGHES K: Black cohosh: Efficacy, safety, and use in clinical and preclinical applications. Altern. Ther. Health Med. (2001) 7:93-100.
2. NO AUTHORS LISTED: Herbal medicine: expanded Commission E monographs (1st edn). (2000).
3. World Health Organization: WHO monographs on selected medicinal plants. Vol.2. Geneva: World Health Organization (2002):55-65.
4. European Scientific Cooperative on Phytotherapy: ESCOP Monographs: the Scientific Foundation for herbal medical products (2ns Edn). Exeter, UK: ESCOP, the European Scientific Cooperative on Phytotherapy; and Stuttgart and New York: Thieme Scientific Publishers. (2003):79-91.
5. PAPPS FA: Therapeutic use and associated biochemistry of Cimcifuga racemosa in the treatment of menopausal symptoms. Aust. J. Med. Herbalism (2000) 12:22-26.
6. HUNTLEY AL, ERNST E: A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause (2003) 10:465-476.
7. BROWN DJ: Is black cohosh a selective estrogen receptor modulator? Herbal Gram. (2004) 61:33-35.
8. GIZICKY HV: Arzneipflanzen in inhren Beziehungen zum weiblichen Genitalsystem. Versucheanweissen ratten und mausen mit Cimicifuga racemosa. Z Ges Exp. Med. (1944) 113:635-644.
9. FREUDENSTEIN J, DASENBROCK C, NISSLEIN T: Lack of promotion of estrogen dependent mammary gland tumors in vivo by an isopropanolic black cohosh extract. Phytomedicine (2000) 7 Suppl. II):13.
10. ZAVA DT, DOLLBAUM CM, BLEN M: Estrogen and progestin bioactivity of foods, herbs and spices. Proc. Soc. Exp. Biol. Med. (1998) 217:369-378.
11. LIU J, BURDETTE JE, XU H et al.: Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. (2001) 49 2472-2479.
12. LEHMANN E, WILLENBROCK RH: Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl. Gynakol. (1988) 110:611-618.
13. LISKE E, HANGGI W, HENNEICKE-VON ZEPLIN H-H et al.: Physiological investigation of a unique extract of black cohosh ( Cimicifugae racemosa rhizoma): a 6 month clinical study demonstrates no systemic estrogenic effect. J. Women's Health Gen B Med. (2002) 11:163-174.
14. EINER-JENSEN N, ZHAO J, ANDERSON K, KRISTOFFERSON K: Cimicifuga and melbrosia lack oestrogenic effects in mice and rats. Maturitas (1996) 25:149-153.
15. LOHNING A, VERSPONHL EJ, WINTERHOFF H: Pharmacological studies on the dopaminergic activity of Cimcifuga racemosa. Proceedings of the 23rd International LOF-symposium on Phytoestrogens, University of Gent, Belgium (1999).
16. LIAO JF, JAN YM, HUANG SY, WANG HH, YU LL, CHEN CF: Evaluation with receptor binding assay on the water extracts of ten CNS active Chinese herbal drugs. Proc. Natl. Sci. Counc. Repub. China Life Sci. B (1995) 19:151-158.
17. YOO JS, JUNG JS, LEE TH et al.: Inhibitory effects of extracts from traditional herbal drugs on 5-hydroxytryptophan-induced diarrhea in mice. Korean J. Pharmacog. (1995) 26:355-359.
18. BURDETTE JE, LIU J, CHEN SN et al.: Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J. Agric. Food Chem. (2003) 51:5661-5670.
19. JARRY H, METTEN M, SPENGLER CHRISTOFFEL V, WUTTKE W: In vitro effects of the Cimcifuga racemosa extract BNO1055. Maturitas (2003) 44(Suppl. 1):S31-S38.
20. SEIDLOVÀ-WUTTKE D, JARRY H, BECKER T, CHRISTOFFEL V, WUTTKE W: Pharmacology of Cimicifiga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas (2003) 44(Suppl. 1 ):S39-S50.
21. WUTTKE W, JARRY H, BECKER T et al.: Phytoestrogens: endocrine disruptors or replacement for hormone replacement therapy. Maturitas (2003) 44(Suppl. 1):S9-S20.
22. NISSLEIN T, FREUDENSTEIN J: Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J. Bone Miner. Metab. (2003) 21:370-376.
23. SAXE EINBOND L, SHIMIZU M, XIAO D et al.: Growth inhibitory activity of extracts and purified components of black cohosh in human breast cancer cells. Breast Cancer Res. Treat. (2004) 83:221-231.
24. NISSLEIN T, FREUDENSTEIN J: Concomitant administration of an isopropanolic extract of black and tamoxifen in the vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells. Toxicol. Lett. (2004) 150:217-215.
25. LUPU R, MEHMI I, ATLAS E et al.: Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. In. J. Oncol. (2003) 23:1407-1412.
26. ZIERAU O, BODINET C, KOLBA S, WULF M, VOLLMER G: Antiestrogenic activities of Cimicifuga racemosa extracts. J. Steroid Biochem. Mol. Biol. (2002) 80:125-130.
27. HOSTANSKA K, NISSLEIN T, FREUDENSTEIN J, REICHLING J, SALLER R: Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat. (2004) 84 151-160.
28. BODINET C, FREUNDENSTEIN J: Influence of Cimcifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells. Breast Cancer Res. Treat. (2002) 76 1-10.
29. KESSELKAUL O: Über die behandlung klimakterischer beschwerden mit remifemin. Med Mschr. (1957) 11:87-88.
30. SCHOTTEN EW: Erfahrungen mit dem Cimcifuga-Präparat Remifemin. Landarzt (1958) 34:353-354
31. FÖLDES J: Die Wirkungen, eines extraktes aus Cimcifuga racemosa. Ärztiche Praxis (1959) 13:623-624.
32. STIEHLER K: Über die anwendung eines standardisierten Cimcifuga-Auszuges in der gynäkologie. Ärztliche Praxis (1959) 27:1-7.
33. HEIZER H: Kritisclies zur cimicifuga-therapie bei hormonalen störungen der frau. Med. Klin. (1960) 6:232-233.
34. STARFINGER W: Therapie mit oestrogen wirksamen pflanzenextrakten. Med. Heute (1960) 9:173-174.
35. BRÜCKER A: Beitrag zur phytotherapie hormonaler störungen der frau. Med. Welt (1960) 44: 2331-2333.
36. GÖRLICH N: Behandlung ovarieller Störungen in der Allgemein praxis. Arztliche Praxis (1962) 25:1742-1743.
37. LANGFRITZ W: Beitrag zur therapie von regelanomalien und deren begleiterscheinungen bei jungen mädchen und jungen frauen. Med. Klin. (1962) 57:1497-1499.
38. SCHILDGE E: Beitrag zur behandlung von prämenstruellen und klimakterischen verstimmungs und depressions-zuständen. Ringelh Biol. Umsch (1964) 19:18-22.
39. STOLZE H: Der andere weg, klimakterische beschwerden zu behandeln. Gyne (1982) 1:14-16.
40. DAIBER W: Klimakterische beschwerden: ohne hormone zum erfolg! Ärztiche Praxis (1983) 65:1-8.
41. VORBERG G: Therapie klimakterischer beschwerden. ZFA (1984) 13:626-629.
42. PETHÖS A: Umstellung einer hormonbehandlung auf ein pflanzliches gynäkologikum möglich. Ärztliche Praxis (1987) 13:1551-1553.
43. DÜKER E, KOPANSKI L, JARRY H, WUTTKE W: Effects of extracts from Cimcifuga racemosa on gonadotrophin release in menopausal women and ovarietomized rats. Planta Med. (1991) 57 420-424. Abstract
44. BAIER-JAGODZINSKI G: Praxisstudie mit cimisan bei klimakterischen beschwerden, prämenstruellem syndrom und dysmenorrhoe. Natur. Heilpraxis mit Naturmedizin (1995) 48:1284-1288.
45. NESSELHUT T, LISKE E: Pharmacological measures in postmenopausal women with an isopropanolic aqueous extract of Cimicifugae racemosa rhizoma. Proceedings of the 10th Annual meeting of the North American Menopause society, New York. (1999).
46. OSMERS R: Wirksamkeit und Verträglichkeit eines isopropanolischen Extraktes aus dem Wurzelstock der Traubensiberkerke. Phytopharmaka und Phytotherapie Forschung und Praxis 26-28 February (2004) Berlin. Abstract.
47. STOLL W: Phytotherapeutikum beeinflusst atrophisches vaginalepithel. Doppelblindversuch cimcifuga versus Östrogenpräparat. Therapeutikon (1987) 1:23-31.
48. WARNECKE G: Influence of a phytopharmaceutical on climacteric complaints. Med Welt (1985) 36:871-874.
49. LEHMANN-WILLENBROCK E, RIEDEL HH: Klinische und endokrinologische untersuchungen zur therapie ovarieller ausfallserscheinungen nach hysterektomie unter belassung der adnexe. Zent bl Gynakol (1988) 110:611-618.
50. WUTTKE W, SEIDLOVA-WUTTKE D, GORKOW C: The Cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas (2003) 44(Suppl 1):S67-S77.
51. FREI-KLEINER S: Wechseljahre: studienergebnisse mit Cimicifuga racemosa. Schweizerischetagungfurphytotherapie. Solthurn, 14 November (2002). Abstract 17.
52. JACOBSON JS, TROXEL AB, EVANS J et al.: Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J. Clin. Oncology (2001) 19 2739-2745.
53. HERNÁNDEZ MUÑOZ G, PLUCHINO S: Cimcifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas (2003) 44(Suppl 1):S59-S65.
54. LISKE E, HÄNGGI W, HENNEICKE-VON ZEPELIN, BOBLITZ N, WÜSTENBERG P, RAHLFS VW: Physiological investigation of a unique extract of black cohosh (Cimcifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gen. Based Med. (2002) 11(2):163-174.
55. JOHNSON BM, VAN BREEMAN R: In vitro formation of quinoid metabolites of the dietary supplement Cimcifuga racemosa (Black Cohosh). Chem. Res. Toxicol. (2003) 16:838-846.
56. WHITING PW, CLOUSTON A, KERLIN P: Black cohosh and other herbal remedies associated with acute hepatitis. MJA (2002) 177 432-435.
57. THOMSEN M, SCHMIDT M: Hepatotoxicity from Cimcifuga racemosa? Recent Australian case report not sufficiently substantiated. J. Altern. Complement Med. (2003) 9 3):337-340.
58. LONTOS S, JONES RM, ANGUS PW, GOW PJ: Acute liver failure associated with the use of herbal preparations containing black cohosh. MJA (2003) 179:390-391.
59. VITETTA L, THOMPSON M, SALF A: Black cohosh and other herbal remedies associated with acute hepatitis. MJA (2003) 178 411-412.
60. HUNTLEY A, ERNST E: A systematic review of the safety of black cohosh. Menopause (2003) 10(1):58-64.